search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
RESPIRATORY DISTRESS IN HORSES


| 609


TABLE 1 Drugs commonly used in the treatment of respiratory distress. Drug


Upper respiratory tract obstruction


Severe equine asthma a Tracheostomy tube placement


Bronchodilators Systemic


Sedation: xylazine Dose


0.2–0.4 mg/kg i.v. (1.0–2.0 mL for 500 kg horse)


N- butylscopolammonium bromide (Buscopan®)


Atropine Clenbuterol Inhaled Albuterol/salbuterol Salmeterol Ipratropium bromide Corticosteroids


Systemic injection recommended in horses with distress


Inhaled corticosteroids less effective in crisis


Hydrostatic pulmonary oedema a


Increased permeability pulmonary oedema a


Pneumothorax and pleural effusion a


Diuretics


Treat underlying disease Corticosteroids for ARDS


Thoracocentesis and drainage Treat underlying condition


a Intranasal oxygen at 10–30 L/min via uni- or bilateral intranasal cannulas is useful if available. Furosemide 1–2 mg/kg i.v. q 4–6 h


Most effective in cardiogenic pulmonary oedema; not effective once hydrostatic pressure has returned to normal


Prednisolone sodium succinate or methylprednisolone


0.1–0.2 mg/kg i.v. divided in 2–4 doses


Based on anecdotal reports in foals and weanlings Dexamethasone Prednisolone


0.05–0.1 mg/kg i.v./i.m./po q 24 h


1.0 mg/kg po s.i.d. 0.3 mg/kg i.v. once 0.02 mg/kg i.v. once 0.75–0.8 μg/kg i.v. q 12 h


1–2 μg/kg q 1–4 h 100 μg/actuation: 5–10


0.25–1.0 μg/kg q 6–8 h 25 μg/actuation: 5–20


0.8–5.5 μg/kg q 6–8 h


Higher risk of systemic side effects than Buscopan®


Anticholinergics might be preferable Onset of action 5 min; duration of action 30–60 min


Onset of action 30 min; peak activity 3 h; duration of action 8 h


Onset of action 30–60 min; duration of action 4–6 h Full effect can take up to 7 days to establish Injectable route preferable


Possibly less effective than dexamethasone Notes


Start with low dose of short acting α- agonist to establish response


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92